The Journal of Medical Microbiology, Vol 30, Issue 1 37-43, Copyright © 1989 by Society for General Microbiology

JOURNAL ARTICLE

Humoral immunity in mice mediated by monoclonal antibodies against the A and M antigens of Brucella

J. N. Limet, N. Bosseray, B. Garin-Bastuji, G. Dubray and M. Plommet
Catholic University of Louvain, Unit of Experimental Medicine, Brussels, Belgium.

All smooth strains of Brucella bear two lipopolysaccharide (LPS) antigens in a ratio that defines the classification of strains in serovars, A (A greater than M), M (M greater than A) and A.M (A = M). Anti-LPS-A monoclonal antibodies (MAb-A) were previously shown to convey protection to mice against B. abortus (A) strain 544, as shown by lower spleen counts than in controls at days 7 and 21 after challenge. Anti-LPS-M monoclonal antibodies (MAb-M) were obtained and tested for M-specificity with LPS from reference strains by ELISA, by agglutination of LPS-coated latex particles, and by inhibition of this agglutination. Antigens A and M of three strains were quantified by a homologous LPS-latex and MAb agglutination inhibition assay. Protection conferred by MAb-A and MAb-M against three strains, B. abortus 544 (A), B. abortus 292 (M) and B. melitensis H38 (M), was tested at equivalent challenge and MAb doses: intravenous challenge was adjusted to give similar infection at day 7; MAb doses were adjusted to the same specific ELISA titre. Under these conditions, MAb-A and MAb-M conferred both early and late protection, as shown at days 7 and 21, against the strains that bore the homologous major antigen, i.e., strain 544 on one hand and strains H38 and 292 on the other. In contrast, MAb directed against the minor antigen of the challenge strain conferred significant protection at day 7 only with strains 544 and H38 and no or inconsistent protection against strain 292, which expressed the lowest amount of minor antigen.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Al-Mariri, A. Tibor, P. Lestrate, P. Mertens, X. De Bolle, and J.-J. Letesson Yersinia enterocolitica as a Vehicle for a Naked DNA Vaccine Encoding Brucella abortus Bacterioferritin or P39 Antigen Infect. Immun., April 1, 2002; 70(4): 1915 - 1923. [Abstract] [Full Text] [PDF]

				A. Al-Mariri, A. Tibor, P. Mertens, X. De Bolle, P. Michel, J. Godefroid, K. Walravens, and J.-J. Letesson Protection of BALB/c Mice against Brucella abortus 544 Challenge by Vaccination with Bacterioferritin or P39 Recombinant Proteins with CpG Oligodeoxynucleotides as Adjuvant Infect. Immun., August 1, 2001; 69(8): 4816 - 4822. [Abstract] [Full Text] [PDF]

				A. Cloeckaert, V. Weynants, J. Godfroid, J.-M. Verger, M. Grayon, and M. S. Zygmunt O-Polysaccharide Epitopic Heterogeneity at the Surface of Brucella spp. Studied by Enzyme-Linked Immunosorbent Assay and Flow Cytometry Clin. Vaccine Immunol., November 1, 1998; 5(6): 862 - 870. [Abstract] [Full Text]

				F. Godfroid, B. Taminiau, I. Danese, P. Denoel, A. Tibor, V. Weynants, A. Cloeckaert, J. Godfroid, and J.-J. Letesson Identification of the Perosamine Synthetase Gene of Brucella melitensis 16M and Involvement of Lipopolysaccharide O Side Chain in Brucella Survival in Mice and in Macrophages Infect. Immun., November 1, 1998; 66(11): 5485 - 5493. [Abstract] [Full Text] [PDF]